AVE avecho biotechnology limited

daptomycin injectable patent priority date, page-3

  1. 3,257 Posts.
    lightbulb Created with Sketch. 744
    I have found this definition of a priority claim very interesting:
    "A claim of priority is a reference in a later filed patent application back to an earlier filed patent application."
    If this definition is correct Agila certainly have no earlier patent application for an improved daptomycin injectable dating back prior to signing of the licensing agreement with POH on 30/10/2012.
    Kens
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $15.86M
Open High Low Value Volume
0.5¢ 0.6¢ 0.4¢ $28.1K 5.620M

Buyers (Bids)

No. Vol. Price($)
43 40990100 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 450000 1
View Market Depth
Last trade - 15.47pm 31/07/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.